Log In
Print this Print this

Symbicort single inhaler therapy (SiT)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSingle inhaler therapy that allows patients the flexibility to adjust dose and take additional inhalations
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today